Détails sur le projet
Description
The general objective of this research project is to elucidate the
mechanism by which deregulated expression of the c-Myc gene
induce B-cell neoplasia. The c-Myc gene encodes a transcription
factor which binds DNA specifically as an heterodimer with its
partner protein Max and regulates cell proliferation, differentiation
and apoptosis by regulating the expression of specific target genes.
Despite the substantial progress in elucidating the function of c-
Myc, the identity of c-Myc target genes, and therefore the
mechanism by which c-Myc contributes to tumorigenesis, remains
unknown. We have recently developed novel experimental
strategies for the identification of c-Myc target genes based on the
use of non-transformed. EBV-immortalized human B cells as
substrates for the identification of c-Myc regulated genes. Using
this approach, we have identified two novel c-Myc target genes: I)
Mxi which codes for a transcription factor which antagonizes the
function of c-Myc by heterodimerizing with Max. Mxi expression
is induced by c-Myc suggesting that Myc-mediated inducted of Mxi
may be part of an autoregulatory circuit that modulates c-Myc
function; ii) H-ferritin, whose expression is suppressed by c-Myc,
and whose enforced expression can revert part of Myc-dependent
transformation phenotype, suggesting that H-ferritin downregulation
may represent a critical component of the Myc-dependent biological
program. Finally, we have established a novel system allowing for
the first time the identification of genes that are regulated upon c-
Myc induction in normal quiescent cells (B cells), the physiologic
context of c-Myc induction. Based on these approaches, the long
term goal of this project is to identify the full spectrum of c-Myc
target genes and test their ability, individually or in combination, to
reproduce part of the c-Myc-dependent phenotype. The
identification of these genes should be instrumental in understanding
the mechanism by which c-Myc regulates growth, differentiation
and apoptosis, as well as its precise contribution to tumorigenesis.
Statut | Terminé |
---|---|
Date de début/de fin réelle | 3/1/85 → 3/31/00 |
Financement
- National Cancer Institute: 375 338,00 $ US
Keywords
- Genética
- Biología molecular
Empreinte numérique
Explorer les sujets de recherche abordés dans ce projet. Ces étiquettes sont créées en fonction des prix/bourses sous-jacents. Ensemble, ils forment une empreinte numérique unique.